Luteolin Isolated from Polygonum cuspidatum Is a Potential Compound against Nasopharyngeal Carcinoma

Table 2

The signaling pathways with from KEGG analysis.

ID	Description	geneID	Count
hsa05167	Kaposi sarcoma-associated herpesvirus infection	PTGS2/BAX/CASP9/JUN/CASP3/CASP8/AKT1/VEGFA/CCND1/CDKN1A/MAPK1/RB1/IL6/NFKBIA/ICAM1/RAF1/HIF1A/STAT1/MYC/CXCL8	20
hsa04151	PI3K-Akt signaling pathway	BCL2/CASP9/EGFR/AKT1/VEGFA/CCND1/BCL2L1/CDKN1A/MAPK1/IL6/MDM2/ERBB2/IL2/IL4/MET/EGF/RAF1/MYC/SPP1/IGF2	20
hsa05161	Hepatitis B	BCL2/BAX/CASP9/JUN/CASP3/CASP8/AKT1/CDKN1A/MMP9/MAPK1/RB1/IL6/NFKBIA/PCNA/BIRC5/RAF1/STAT1/MYC/CXCL8	19
hsa05163	Human cytomegalovirus infection	PTGS2/BAX/CASP9/CASP3/CASP8/EGFR/AKT1/VEGFA/CCND1/CDKN1A/MAPK1/RB1/IL6/NFKBIA/MDM2/RAF1/MYC/IL1B/CXCL8	19
hsa05205	Proteoglycans in cancer	CASP3/EGFR/AKT1/VEGFA/CCND1/CDKN1A/MMP2/MMP9/MAPK1/MDM2/ERBB2/MET/PLAU/RAF1/HIF1A/CAV1/MYC/IGF2	18
hsa05215	Prostate cancer	BCL2/CASP9/EGFR/AKT1/CCND1/CDKN1A/MMP9/MAPK1/RB1/NFKBIA/MDM2/ERBB2/GSTP1/MMP3/PLAU/EGF/RAF1	17
hsa05206	MicroRNAs in cancer	PTGS2/BCL2/CASP3/EGFR/VEGFA/CCND1/CDKN1A/MMP9/MAPK1/TP63/MDM2/ERBB2/MET/PLAU/RAF1/MYC/RASSF1	17
hsa05219	Bladder cancer	EGFR/VEGFA/CCND1/CDKN1A/MMP2/MMP9/MAPK1/RB1/MDM2/MMP1/ERBB2/EGF/RAF1/MYC/CXCL8/RASSF1	16
hsa05160	Hepatitis C	BAX/CASP9/CASP3/CASP8/EGFR/AKT1/CCND1/CDKN1A/MAPK1/RB1/NFKBIA/IFNG/EGF/RAF1/STAT1/MYC	16
hsa05169	Epstein-Barr virus infection	BCL2/BAX/CASP9/JUN/CASP3/CASP8/AKT1/CCND1/CDKN1A/RB1/IL6/NFKBIA/MDM2/ICAM1/STAT1/MYC	16
hsa05165	Human papillomavirus infection	PTGS2/BAX/CASP3/CASP8/EGFR/AKT1/VEGFA/CCND1/CDKN1A/MAPK1/RB1/MDM2/EGF/RAF1/STAT1/SPP1	16
hsa04630	JAK-STAT signaling pathway	BCL2/EGFR/AKT1/CCND1/BCL2L1/CDKN1A/IL10/IL6/IL2/IFNG/IL4/EGF/RAF1/STAT1/MYC	15
hsa04010	MAPK signaling pathway	JUN/CASP3/EGFR/AKT1/VEGFA/MAPK1/ERBB2/MET/EGF/RAF1/MYC/IL1B/HSPB1/IGF2/RASA1	15